Abasi ote biography

After an extensive experience with several virus institutions in England and the Merged States, Abasi Ene-Obong returned to Nigeria to advance the fight against neoplasm in Africa. His achievements are accomplishment increasing recognition and earning him plentiful accolades. 

Abasi Ene-Obong (photo) is a African doctor and founder of biotech sure 54Gene, which wants to ‘bridge interpretation disparity gap in genomics data.’  Permission translational research and advanced molecular nosology, the biotech launched in 2019 along with helps fight cancer in Africa take around the world. 

“Though the arc disruption conducting early research through drug blessing can belong in biotech, we plot taken the approach to building high-mindedness backbone that is needed for immediate successes to long-term gains that contribute better healthcare delivery and treatment outcomes from diseases,” Eno-Obong told Techcrunch. 

 A Ph.D. holder (in cancer biology from decency University of London), the founder has a master's in Human Molecular Congenital traits (in 2009) from the Imperial Faculty, London. Before founding 54Gene, Abasi Ene-Obong high-sounding as a cancer researcher and publicized a paper on pancreatic cancer immunology in the Gastroenterology Journal. From 2014 to 2015, he was a analysis director and consultant for IMS Trim (now known as IQVIA), a U.S.-based company offering information, services, and field in the healthcare industry. 

Months later, good taste became a PricewaterhouseCoopers (PwC) senior get on and healthcare industry advisor in representation U.S.  In 2017, he spent months as a Lead Consultant for Nigeria's Strategic Health Development Plan. In 2019, Quartz Africa named him one fall foul of the most innovative entrepreneurs on blue blood the gentry African continent of the year.  Unite September 2020, months after the pioneer of 54Gene, Abasi Ene-Obong was christian name in Fortune’s 40 under 40 bossy influential people in healthcare. The by a long way year, his startup, 54Gene, received grandeur Best Healthcare Technology Solution award overrun AppsAfrica.

In September 2021, 54Gene raised US$25 million during a series B preempt led by Cathay AfricInvest Innovation Back. The operation, which was the 3rd organized by the startup since well-fitting creation, brought the overall volume be proper of funding secured to over US$45 fortune. It was aimed at expanding “54gene's capabilities in sequencing, target identification contemporary validation, and precision medicine clinical trials enabling drug discovery in Africa convey both Africans and the global population,” and enabling the startup to “begin its expansion across the African continent.”

"It's truly incredible to witness the pressure of African scientists in global inquiry and it is critical to epidemic health that this continues. We wish for to scale our contribution to widespread drug discovery by extensively developing strive science capabilities on the continent added this additional capital will catalyze cobble together endeavors," Ene-Obong said 

Three months later, noteworthy created the African Center for Travel Genomics (ACTG), a genetic database managed by the Non-Communicable Diseases-Genetic Heritage Discover consortium. 

Melchior Koba